Literature DB >> 22888392

Capecitabine plus Cisplatin treatment for advanced gastric cancer in a patient with hepatic impairment secondary to metastases.

Hisato Kawakami1, Shin-Ichi Nishina, Shinya Ueda, Toshihiro Kudo, Wataru Okamoto, Takayasu Kurata, Isamu Okamoto, Kazuhiko Nakagawa.   

Abstract

Entities:  

Year:  2012        PMID： 22888392      PMCID： PMC3415725     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  17 in total

1.  Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites.

Authors:  C Twelves; R Glynne-Jones; J Cassidy; J Schüller; T Goggin; B Roos; L Banken; M Utoh; E Weidekamm; B Reigner
Journal:  Clin Cancer Res       Date:  1999-07       Impact factor: 12.531

2.  Hepatic resection for metastatic tumors from gastric cancer.

Authors:  Keiichi Okano; Takashi Maeba; Ken Ishimura; Yukihiko Karasawa; Fuminori Goda; Hisao Wakabayashi; Hisashi Usuki; Hajime Maeta
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

Review 3.  Chemotherapy dosing in the setting of liver dysfunction.

Authors:  John W Eklund; Steve Trifilio; Mary F Mulcahy
Journal:  Oncology (Williston Park)       Date:  2005-07       Impact factor: 2.990

Review 4.  Capecitabine: a review.

Authors:  Christine M Walko; Celeste Lindley
Journal:  Clin Ther       Date:  2005-01       Impact factor: 3.393

5.  Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients.

Authors:  J Schüller; J Cassidy; E Dumont; B Roos; S Durston; L Banken; M Utoh; K Mori; E Weidekamm; B Reigner
Journal:  Cancer Chemother Pharmacol       Date:  2000       Impact factor: 3.333

Review 6.  Cisplatin: a review of toxicities and therapeutic applications.

Authors:  K Barabas; R Milner; D Lurie; C Adin
Journal:  Vet Comp Oncol       Date:  2008-03       Impact factor: 2.613

7.  Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients.

Authors:  Yoshihiro Sakamoto; Shigekazu Ohyama; Junji Yamamoto; Kazuhiko Yamada; Makoto Seki; Kei-ichiro Ohta; Norihiro Kokudo; Toshiharu Yamaguchi; Tetsuichiro Muto; Masatoshi Makuuchi
Journal:  Surgery       Date:  2003-05       Impact factor: 3.982

8.  Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.

Authors:  C L Litterst; T E Gram; R L Dedrick; A F Leroy; A M Guarino
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

9.  Capecitabine as salvage therapy for a breast cancer patient with extensive liver metastases and associated impairment of liver function.

Authors:  B Schüll; W Scheithauer; G V Kornek
Journal:  Onkologie       Date:  2003-12

10.  Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.

Authors:  Daniele Marrelli; Franco Roviello; Alfonso De Stefano; Giuseppe Fotia; Camillo Giliberto; Lorenzo Garosi; Enrico Pinto
Journal:  J Am Coll Surg       Date:  2004-01       Impact factor: 6.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.